Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000193808 | SCV000248912 | uncertain significance | not specified | 2015-02-12 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001721262 | SCV000514687 | likely benign | not provided | 2021-04-22 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000648092 | SCV000769902 | likely benign | GLUT1 deficiency syndrome 1, autosomal recessive | 2024-01-27 | criteria provided, single submitter | clinical testing | |
Center for Genomics, |
RCV000768318 | SCV000898978 | uncertain significance | Hereditary cryohydrocytosis with reduced stomatin; Dystonia 9; Encephalopathy due to GLUT1 deficiency; Childhood onset GLUT1 deficiency syndrome 2; Epilepsy, idiopathic generalized, susceptibility to, 12 | 2021-03-30 | criteria provided, single submitter | clinical testing | SLC2A1 NM_006516 exon 10 p.Ser465Ser (c.1395C>T): This variant has not been reported in the literature but is present in 4/34420 Latino alleles in the Genome Aggregation Database (http://gnomad.broadinstitute.org/rs75852730). This variant is present in ClinVar (Variation ID:212203). Evolutionary conservation and computational predictive tools for this variant are limited or unavailable. Of note, this variant is a silent variant and does not change the amino acid, reducing the probability that this variant is disease causing. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. |
Ambry Genetics | RCV002390507 | SCV002701679 | likely benign | Inborn genetic diseases | 2017-11-14 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |